BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Pharmacyclics, Inc. 

995 East Arques Avenue

Sunnyvale  California  94086  U.S.A.
Phone: 408-774-0330 Fax: 408-774-0340


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Pharmacyclics, Inc. (PCYC) Release: IMBRUVICA® (ibrutinib) Data To Be Presented Across Multiple Histologies, Including In Eight Oral Presentations, At 2014 American Society of Hematology Annual Meeting 11/6/2014 9:15:21 AM
Pharmacyclics, Inc. (PCYC), AstraZeneca PLC (AZN) Partnership Holds Tumor Promise: Citi 11/5/2014 5:31:02 PM
Pharmacyclics, Inc. (PCYC) Reports Third Quarter 2014 Financial Results And Provides Clinical Program Update 11/5/2014 7:47:12 AM
AstraZeneca PLC (AZN) And Pharmacyclics, Inc. (PCYC) Enter Clinical Trial Collaboration To Evaluate IMBRUVICA® In Hematologic Cancers 11/5/2014 7:32:36 AM
AstraZeneca PLC (AZN) And Pharmacyclics, Inc. (PCYC) Enter Immuno-Oncology Clinical Trial Collaboration With IMBRUVICA® In Solid Tumors 11/4/2014 9:47:52 AM
AstraZeneca PLC (AZN) Strengthens Cancer Biz With Johnson & Johnson (JNJ), Pharmacyclics, Inc. (PCYC) Deals 11/4/2014 6:06:33 AM
Pharmacyclics, Inc. (PCYC) Announces Conference Call To Discuss Third Quarter Financial Results 10/29/2014 7:22:16 AM
Pharmacyclics, Inc. (PCYC) Files Supplemental New Drug Application For IMBRUVICA® For Waldenstrom's Macroglobulinemia 10/20/2014 8:29:51 AM
Pharmacyclics, Inc. (PCYC) Release: IMBRUVICA® (ibrutinib) Now Approved In Europe for Treatment Of Two Blood Cancers 10/17/2014 8:02:09 AM
Pharmacyclics, Inc. (PCYC) Enters Into Agreement With Roche (RHHBY) To Evaluate IMBRUVICA® And GAZYVA® In Lymphoma And Leukemia 10/16/2014 1:04:05 PM
12345678910...